Search

Displaying results 6621 - 6630 of 7639 in total
  1. Drug

    Scutellaria baicalensis root

    go.drugbank.com/drugs/DB14364
    Investigational

    It is not an approved drug.

  2. Drug

    Typhonium giganteum whole

    go.drugbank.com/drugs/DB14369
    Investigational

    It is not an approved drug.

  3. Drug

    Phellodendron amurense bark

    go.drugbank.com/drugs/DB14370
    Investigational

    It is not an approved drug.

  4. Drug

    Quercus acutissima whole

    go.drugbank.com/drugs/DB14373
    Investigational

    It is not an approved drug.

  5. Drug

    Demplatin pegraglumer

    go.drugbank.com/drugs/DB14807
    Investigational

    Demplatin pegraglumer is under investigation in clinical trial NCT02043288 (Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer).

    Synonyms: NC-6004 nanoplatin
  6. Drug

    Bermekimab

    go.drugbank.com/drugs/DB14947
    Investigational

    Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).

  7. Drug

    Sevuparin

    go.drugbank.com/drugs/DB15007
    Investigational

    Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).

  8. Drug

    Vunakizumab

    go.drugbank.com/drugs/DB15154
    Investigational

    Vunakizumab is under investigation in clinical trial NCT03463187 (Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis).

  9. Drug

    Norbixin

    go.drugbank.com/drugs/DB15201
    Experimental

    Norbixin is under investigation in clinical trial NCT03820245 (Effect of Short-term Annatto Carotenoids Supplementation on Oxidative Stress Status in Healthy Individuals).

  10. Drug

    Batoclimab

    go.drugbank.com/drugs/DB16104
    Investigational

    Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP).